Morning Market Losers By: Benzinga via Benzinga October 06, 2014 at 09:47 AM EDT Sunesis Pharmaceuticals (NASDAQ: SNSS) shares dipped 69.88% to $2.00 as pivotal Phase 3 VALOR trial of acute myeloid leukemia treatment ... Read More >> Related Stocks: Arcturus Therapeutics Holdings Inc Biocryst Pharma Inc H&R Block Micron Technology